Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
One Lambda Devyser Chimerism Plus is an improved NGS assay for chimerism analysis, developed to help laboratories streamline complex workflows while generating high-quality data.
Built on the proven foundation of One Lambda Devyser Chimerism, this version introduces an innovative assay design with 49 highly discriminative indel markers that reduces complexity and minimizes sources of error associated with high-complexity assays, making it easier to generate reliable sequencing results with confidence.
One Lambda Devyser Chimerism Plus is the next evolution of the trusted Devyser Chimerism assay. It has been redesigned to improve assay performance, streamline laboratory workflows, and minimize sources of analytical complexity. Building on the trusted foundation of Devyser chimerism assay, the Chimerism Plus version expands from 24 to 49 highly discriminative indel markers, increasing genomic coverage from 16 to 21 chromosomes. This enhanced marker panel provides greater flexibility when identifying informative markers, helping laboratories maximize marker informativity across a wider range of donor-recipient pairs while maintaining a streamlined NGS workflow.
The result is a robust solution that helps laboratories generate reliable results while improving operational efficiency.
One Lambda Devyser Chimerism Plus – Product features
Discover how our product can fit your laboratory needs.

Generate highly reproducible results for accurate donor-recipient chimerism analysis. Reliable data quality across runs helps support confident decision making.
Simplified workflow
Designed to minimize hands-on time and simplify laboratory implementation without compromising performance. Suitable for laboratories processing both routine and high sample volumes.
A redesigned assay architecture that reduces errors associated with high-complexity workflows. Contains 49 indels (3-5 bp) across 21 chromosomes for optimized genetic distinction. These indels are population-independent, making our assay suitable for all populations.
One Lambda Devyser Chimerism Plus is launched in collaboration with Thermo Fisher Scientific's One Lambda™ business, further strengthening a long-standing partnership dedicated to supporting laboratories with innovative solutions for transplantation diagnostics. Read the press release here
Why upgrade to One Lambda Devyser Chimerism Plus?
If you're already using One Lambda Devyser Chimerism, the Plus version provides an enhanced experience through an improved assay design focused on:
Reduced workflow complexity
Improved robustness
Lower risk of assay-related errors
Optimized laboratory efficiency
Future-ready performance
.png?width=2000&height=1122&name=MicrosoftTeams-image%20(8).png)
Discover how One Lambda Devyser Chimerism Plus can simplify your laboratory workflow while delivering reliable performance for post-transplant monitoring.
Instructions for use
Enter access code found in the lower right corner of the label on the kit box.
Certificates
Download a specific Batch Release Certificate (BRC) below.
Guidelines and handbooks (2)
Product information (0)
Software settings (4)
Safety data sheets (1)
Data tables (0)
Enter access code found in the lower right corner of the label on the kit box.
Download a specific Batch Release Certificate (BRC) below.
RUO
One Lambda Devyser Chimerism Plus
Detection of mixed chimerism
8-A423-24
8-A423-48
Pack size: 24
Pack size: 48
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
Read More
Alloimmunization against Rhesus D (RhD) is the leading cause of hemolytic disease of the fetus and...
Read More
For many laboratories, CFTR testing is not an occasional add-on. It is part of a routine,...
Read More